Cargando…
Construction and characterization of a new TRAIL soluble form, active at picomolar concentrations
Apoptosis induction has emerged as a treatment option for anticancer therapy. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), a type II transmembrane protein, is a potent and specific pro-apoptotic protein ligand, which activates the extrinsic apoptosis pathway of the cell death rec...
Autores principales: | Melendez, Matias Eliseo, Silva-Oliveira, Renato José, Silva Almeida Vicente, Anna Luiza, Rebolho Batista Arantes, Lidia Maria, Carolina de Carvalho, Ana, Epstein, Alberto Luis, Reis, Rui Manuel, Carvalho, André Lopes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007462/ https://www.ncbi.nlm.nih.gov/pubmed/29930761 http://dx.doi.org/10.18632/oncotarget.25519 |
Ejemplares similares
-
Combined effect of the pro-apoptotic rhTRAIL protein and HSV-1 virus in head and neck cancer cell lines
por: Bravo Perina, Lucas, et al.
Publicado: (2023) -
Evaluation of acetylation and methylation in oral rinse of patients with head and neck cancer history exposed to valproic acid
por: Gama, Ricardo Ribeiro, et al.
Publicado: (2021) -
Genetic and epigenetic characterization of the BRCA1 gene in Brazilian women at-risk for hereditary breast cancer
por: Felicio, Paula Silva, et al.
Publicado: (2016) -
DNA Methylation Markers from Negative Surgical Margins Can Predict Recurrence of Oral Squamous Cell Carcinoma
por: Sorroche, Bruna Pereira, et al.
Publicado: (2021) -
MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol
por: Arantes, Lidia Maria Rebolho Batista, et al.
Publicado: (2016)